These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7314875)

  • 21. Hippuric acid as a marker.
    Vanholder R; Schoots A; Cramers C; De Smet R; Van Landschoot N; Wizemann V; Botella J; Ringoir S
    Adv Exp Med Biol; 1987; 223():59-67. PubMed ID: 3447451
    [No Abstract]   [Full Text] [Related]  

  • 22. Toxicity of uremia: physiopathology and clinical signs.
    Bergström J
    Contrib Nephrol; 1989; 71():1-9. PubMed ID: 2680257
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on uremic toxins--biochemical analysis of uremic serum (author's transl)].
    Gejyo F
    Nihon Jinzo Gakkai Shi; 1978 Mar; 20(3):199-214. PubMed ID: 353340
    [No Abstract]   [Full Text] [Related]  

  • 24. Separation of peptidic inhibitor of erythropoiesis in uremia.
    Saito A; Ogawa H; Chung TG; Hotta T
    Adv Exp Med Biol; 1987; 223():111-4. PubMed ID: 3447424
    [No Abstract]   [Full Text] [Related]  

  • 25. "Middle molecules" in acute experimental uremia.
    Lutz W; Madry K; Grande G
    Acta Med Pol; 1978; 19(4):417-24. PubMed ID: 752244
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of platelet function by uremic middle molecules.
    Bazilinski N; Shaykh M; Dunea G; Mamdani B; Patel A; Czapek E; Ahmed S
    Nephron; 1985; 40(4):423-8. PubMed ID: 4022211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The road toward the identification of middle molecules. Preliminary Committee Meeting, Avignon, France November 28-29, 1980.
    Bergstrom J; Funck-Brentano JL; Klinkmann H
    Artif Organs; 1980 Aug; 4(3):209-10. PubMed ID: 7417037
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
    Ringoir SM; van Landschoot N; de Smet R
    Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of trasylol on the concentration of middle-sized molecules of urea and creatinine in the plasma in acute experimental uremia].
    Madry K; Lutz W; Grande G
    Pol Tyg Lek; 1978 Jan; 33(1):5-8. PubMed ID: 306100
    [No Abstract]   [Full Text] [Related]  

  • 30. Technical aspects on middle molecules: separation, isolation, and identification.
    Cueille G; Man NK; Sausse A; Farges JP; Funck-Brentano JL
    Artif Organs; 1981; 4 Suppl():8-12. PubMed ID: 7295100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methodology for identification of serum middle molecules.
    Buzio C; Montagna G; Calderini C; Manari A; Migone L
    Artif Organs; 1981; 4 Suppl():22-7. PubMed ID: 7295090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Search for peptidic "middle molecules" in uremic sera: isolation and chemical identification of fibrinogen fragments.
    Kaplan B; Cojocaru M; Unsworth E; Knecht A; Martin BM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 796(1):141-53. PubMed ID: 14552825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Removal of high-molecular-weight toxins.
    Hörl WH
    Contrib Nephrol; 1992; 96():138-44. PubMed ID: 1740048
    [No Abstract]   [Full Text] [Related]  

  • 34. The insulin-resistance inducing factor associated with uremia.
    Lockwood DH; Hayes GR; McCaleb ML
    Adv Exp Med Biol; 1987; 223():97-104. PubMed ID: 3447455
    [No Abstract]   [Full Text] [Related]  

  • 35. A compound from uremic plasma and from normal urine isolated by liquid chromatography and identified by nuclear magnetic resonance.
    Gallice P; Monti JP; Crevat A; Durand C; Murisasco A
    Clin Chem; 1985 Jan; 31(1):30-4. PubMed ID: 3965216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Separation, isolation, and identification of middle molecules.
    Bergström J; Fürst P; Zimmerman L
    Artif Organs; 1981; 4 Suppl():5-7. PubMed ID: 7295096
    [No Abstract]   [Full Text] [Related]  

  • 37. Analysis of plasma middle molecular fraction in uremic patients.
    Kovalishin YaF
    Biomater Artif Cells Artif Organs; 1987; 15(3):605-10. PubMed ID: 3440134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of the determination of the blood serum levels of middle molecules for screening azotemia].
    Titel'man KM; Mustafaeva TM; Ianovskaia IK
    Lab Delo; 1986; (3):143-5. PubMed ID: 2421080
    [No Abstract]   [Full Text] [Related]  

  • 39. GIP and DIP: a new view of uraemic toxicity.
    Haag-Weber M; Mai B; Cohen G; Hörl WH
    Nephrol Dial Transplant; 1994; 9(4):346-7. PubMed ID: 8084443
    [No Abstract]   [Full Text] [Related]  

  • 40. Parathyroid hormone as a uremic toxin: its influence on T lymphocyte receptors.
    Giacchino F; Quattrocchio G; Piccoli G
    Clin Nephrol; 1985 Feb; 23(2):105-6. PubMed ID: 3872757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.